Skip to content
Back to Guavy Wire
Stocks

Citizens Jmp Reiterates 'Market Outperform' Rating for Salesforce

Instruments
CRM
Share

Equities research analysts at Citizens Jmp have reiterated their 'market outperform' rating for Salesforce (NYSE:CRM), setting a target price of $315.00 per share, which represents a potential upside of 50.58% from the stock's previous close.

This is not the only positive view on the company; other analysts, such as HSBC and Raymond James Financial, have also issued 'buy' ratings with higher target prices.

However, Phillip Securities downgraded Salesforce from a 'buy' rating to a 'hold' rating, citing a lower target price of $166.00 per share.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc